| Literature DB >> 17689750 |
Turgay Celik, Atila Iyisoy, U Cagdas Yuksel, Ersoy Isik.
Abstract
In the light of current data obtained from prospective outcome studies, we believe that it is premature to support the use of homocysteine-lowering vitamins including folic acid in patients with established coronary artery disease in order to improve cardiovascular outcomes. We think that future large-scale epidemiological trials with very long-term follow-up periods will probably solve this dilemma.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17689750 DOI： 10.1016/j.ijcard.2007.05.044
Source DB: PubMed Journal: Int J Cardiol ISSN： 0167-5273 Impact factor: 4.164